# Purdue Drug Discovery Training Program

> **NIH NIH T32** · PURDUE UNIVERSITY · 2022 · $208,145

## Abstract

Abstract
 The objective of the Purdue Drug Discovery Training Program (PDD-TP) is to provide
predoctoral students with a comprehensive and balanced perspective of drug discovery and
development, and to develop a multi-disciplinary approach toward the design of novel molecular
entities with promising medicinal activity, with subsequent optimization and preclinical
evaluation. Trainees will take an integrated curriculum that expands their breadth of knowledge
and experimental approach toward the discovery of novel targets for drug development, and will
participate in a research embedding project outside their primary laboratory for further
experience and training. Trainees will also participate in program-specific activities intended to
enhance communication, critical thinking, leadership, management, mentorship, networking,
and entrepreneurism. Activities include a journal club, formal presentations of cross-disciplinary
research, organization of seminars in drug discovery, unique opportunities to engage experts in
the evaluation of drug pipeline candidates, and participation in a mock drug panel review. Every
effort will be made to maximize the diversity of training program applicants, and to recruit and
retain trainees of diverse backgrounds. PDD-TP trainees will graduate with a comprehensive
skill set and exposure to drug discovery and pipeline development, and with experiences that
will continue to serve them long after they enter the biomedical workforce.

## Key facts

- **NIH application ID:** 10428481
- **Project number:** 5T32GM125620-04
- **Recipient organization:** PURDUE UNIVERSITY
- **Principal Investigator:** Emily Carla Dykhuizen
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $208,145
- **Award type:** 5
- **Project period:** 2019-07-01 → 2024-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10428481

## Citation

> US National Institutes of Health, RePORTER application 10428481, Purdue Drug Discovery Training Program (5T32GM125620-04). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10428481. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
